Background Diffuse large B‐cell lymphoma, NOS (DLBCL NOS) is the commonest
extranodal non‐Hodgkin lymphoma diagnosed in the oral and maxillofacial region …

Abstract Objectives Non-Hodgkin lymphoma occurs with increasing frequency in HIV/AIDS.
As South Africa has the highest incidence of HIV/AIDS worldwide, an epidemiologic study of …

Plasmablastic lymphoma (PBL) is an aggressive B-cell non-Hodgkin lymphoma associated
with immunodeficiency in the context of human immunodeficiency virus (HIV) infection or …

HIV-infected patients have an increased risk for both Hodgkin and non-Hodgkin lymphomas.
A retrospective cohort of all HIV-infected patients diagnosed with lymphoma in urban clinics …

Human immunodeficiency virus (HIV) infection is endemic in South Africa. Non-Hodgkin
lymphoma (NHL) occurs with increased frequency in HIV seropositive individuals. The …

Diffuse large B-cell lymphoma, not otherwise specified (DLBCL NOS) is subdivided
according to the cell-of-origin (COO) classification into germinal centre B-cell (GCB) and …

Background: Diffuse large B-cell lymphoma (DLBCL) is a high-grade non-Hodgkin
lymphoma with increased incidence among people living with HIV-infection (PLWH) …

Background: Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease that
includes a wide spectrum of lymphomas posing challenges in diagnosis and treatment …

High-grade non-Hodgkin's lymphomas with plasmablastic differentiation are frequently
encountered in HIV-positive patients. Differentiating between diffuse large B cell lymphoma …

Purpose Improving cancer outcomes in Sub-Saharan Africa (SSA) requires effective
implementation of evidence-based strategies. This scoping review maps the evidence on …